PREVALENCE AND INFLUENCE OF MYCOPLASMA-HOMINIS AND UREAPLASMA-UREALYTICUM IN 218 AFRICAN PREGNANT-WOMEN AND THEIR INFANTS

被引:16
作者
LUTON, D
VILLE, Y
LUTONSIGY, A
COUSIN, C
NARRAIDO, B
FASSASIJARRETOU, A
ESCARGUEL, C
机构
[1] CTR INT RECH MED FRANCEVILLE, FRANCEVILLE, GABON
[2] CTR HOSP FRANCEVILLE, FRANCEVILLE, GABON
[3] CHR HYERES, HYERES, FRANCE
关键词
UREAPLASMA UREALYTICUM; MYCOPLASMA HOMINIS; PREGNANCY; ERYTHROMYCIN; NEONATES;
D O I
10.1016/0028-2243(94)90263-1
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To estimate the prevalence of Ureaplasma urealyticum (Mh) and Mycoplasma hominis (Mh) in the lower genital tract of pregnant women, their evolution during pregnancy, and the effect of these pathogens on the outcome of pregnancy in Equatorial Africa, Study design: 218 pregnant women were followed from before 20 weeks gestational age through delivery. Samples were taken from the cervix at every visit and from the newborn at delivery and tested for Uu and Mh. The data were analysed using Student's t-test, the Mann-Whitney, or the X(2)-test. Results: The prevalence of cervical colonization by Ureaplasma urealyticum and Mycoplasma hominis in pregnant women was 79% and 41% respectively. Colonization with Uu and Mh increased significantly throughout pregnancy (P < 0.001). Their presence was associated with lower gestational age at delivery, lower birth weight and increased neonatal morbidity and mortality (P < 0.05). Erythromycin therapy did not have any effect on the evolution of Uu and Mh colonization during pregnancy. Conclusion: Uu and Mh are additional factors that might contribute to poor pregnancy outcome in a country where neonatal health is already impaired by many other microorganism.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 27 条
[1]  
CAREY JC, 1991, AM J OBSTET GYNECOL, V164, P728
[2]  
CASPI E, 1976, OBSTET GYNECOL, V48, P682
[3]   PERINATAL MYCOPLASMAL INFECTIONS [J].
CASSELL, GH ;
WAITES, KB ;
CROUSE, DT .
CLINICS IN PERINATOLOGY, 1991, 18 (02) :241-262
[4]   A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF ERYTHROMYCIN FOR THE TREATMENT OF UREAPLASMA-UREALYTICUM TO PREVENT PREMATURE DELIVERY [J].
ESCHENBACH, DA ;
NUGENT, RP ;
RAO, AV ;
COTCH, MF ;
GIBBS, RS ;
LIPSCOMB, KA ;
MARTIN, DH ;
PASTOREK, JG ;
RETTIG, PJ ;
CAREY, JC ;
REGAN, JA ;
GEROMANOS, KL ;
LEE, MLF ;
POOLE, WK ;
EDELMAN, R .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (03) :734-742
[5]   ENHANCEMENT OF COLONIZATION OF UREAPLASMA-UREALYTICUM IN THE MOUSE GENITAL-TRACT BY ESTROGEN-TREATMENT [J].
IWASAKA, T ;
WADA, T ;
SUGIMORI, H .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 155 (05) :1124-1127
[6]   GENITAL MYCOPLASMA COLONIZATION IN NEONATAL GIRLS [J].
IWASAKA, T ;
WADA, T ;
KIDERA, Y ;
SUGIMORI, H .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1986, 65 (03) :269-272
[7]  
IWASAKA T, 1986, OBSTET GYNECOL, V68, P263
[8]  
KISBEY P, 1991, RAPID DETECTION UREA
[9]   UREAPLASMA-UREALYTICUM INCRIMINATED IN PERINATAL MORBIDITY AND MORTALITY [J].
KUNDSIN, RB ;
DRISCOLL, SG ;
PELLETIER, PA .
SCIENCE, 1981, 213 (4506) :474-476
[10]   WOUND INFECTIONS AFTER CESAREAN-SECTION WITH MYCOPLASMA-HOMINIS AND UREAPLASMA-UREALYTICUM - A REPORT OF 3 CASES [J].
MACCATO, M ;
FARO, S ;
SUMMERS, KL .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1990, 13 (05) :363-365